Both authors contributed equally to this work.
Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
Version of Record online: 1 SEP 2010
Copyright © 2010 EMBO Molecular Medicine
EMBO Molecular Medicine
Volume 2, Issue 9, pages 349–370, September 2010
How to Cite
McConoughey, S. J., Basso, M., Niatsetskaya, Z. V., Sleiman, S. F., Smirnova, N. A., Langley, B. C., Mahishi, L., Cooper, A. J. L., Antonyak, M. A., Cerione, R. A., Li, B., Starkov, A., Chaturvedi, R. K., Beal, M. F., Coppola, G., Geschwind, D. H., Ryu, H., Xia, L., Iismaa, S. E., Pallos, J., Pasternack, R., Hils, M., Fan, J., Raymond, L. A., Marsh, J. L., Thompson, L. M. and Ratan, R. R. (2010), Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. EMBO Mol Med, 2: 349–370. doi: 10.1002/emmm.201000084
- Issue online: 1 SEP 2010
- Version of Record online: 1 SEP 2010
- Manuscript Accepted: 23 JUN 2010
- Manuscript Revised: 18 JUN 2010
- Manuscript Received: 4 AUG 2009
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.